Asset Management One Co. Ltd. Sells 248 Shares of DaVita Inc. (NYSE:DVA)

Asset Management One Co. Ltd. decreased its holdings in DaVita Inc. (NYSE:DVA) by 1.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 19,381 shares of the company’s stock after selling 248 shares during the quarter. Asset Management One Co. Ltd.’s holdings in DaVita were worth $2,990,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the company. MML Investors Services LLC lifted its position in shares of DaVita by 1.3% during the 3rd quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock worth $869,000 after buying an additional 68 shares in the last quarter. Exchange Traded Concepts LLC grew its position in shares of DaVita by 8.3% during the 4th quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock valued at $133,000 after purchasing an additional 68 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in shares of DaVita by 1.5% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,759 shares of the company’s stock valued at $776,000 after purchasing an additional 70 shares in the last quarter. Impact Partnership Wealth LLC lifted its holdings in shares of DaVita by 3.7% during the 4th quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock worth $290,000 after acquiring an additional 70 shares during the last quarter. Finally, Contravisory Investment Management Inc. lifted its holdings in shares of DaVita by 1.2% during the 4th quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock worth $910,000 after acquiring an additional 73 shares during the last quarter. Institutional investors own 90.12% of the company’s stock.

Analyst Ratings Changes

Separately, Barclays lifted their price objective on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, DaVita currently has an average rating of “Hold” and an average target price of $162.80.

DaVita Stock Performance

DaVita stock opened at $154.84 on Thursday. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The company has a market capitalization of $12.39 billion, a PE ratio of 14.42, a P/E/G ratio of 0.79 and a beta of 0.94. The firm has a fifty day simple moving average of $161.40 and a two-hundred day simple moving average of $157.89. DaVita Inc. has a twelve month low of $119.42 and a twelve month high of $179.60.

DaVita (NYSE:DVA) last released its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Research analysts expect that DaVita Inc. will post 10.93 EPS for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.